A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction

Clinical trial NCT00203476 · COMPLETED

Trial details

NCT number: NCT00203476
Sponsor: Tuscaloosa Research & Education Advancement Corporation
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hyperlipidemia Hypercholesterolemia

Start date: 2005-05-01
Primary completion: 2008-01-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.